Skip to main content

Developing DNA Vaccines Against Immunodeficiency Viruses

  • Chapter
DNA Vaccination/Genetic Vaccination

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 226))

Abstract

More than a decade after the identification of human immunodeficiency virus-1 (HIV-1) as the causative pathogen of AIDS, the prospects for an HIV-1 vaccine in the foreseeable future are still low. Attempts using conventional vaccine approaches have not met with much success (for recent reviews see Haynes 1993; Bolognesi 1993, 1995). The live attenuated vaccine approach appeared promising when its effectiveness was demonstrated in a simian immunodeficiency virus (SIV) model in macaques (Daniel et al. 1994, 1992). However, additional studies in neonatal macaques raised safety concerns regarding this approach (Baba et al. 1995). The search for novel vaccine strategies that target the unique biological features of HIV-1 remains a challenging yet important task.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anderson KP, Lucas C, Hanson CV, Londe HF, Izu A, Gregory T, Ammann A, Berman PW, Eichberg JW (1989) Effect of dose and immunization schedule on immune response of baboons to recombinant glycoprotein 120 of HIV-1. J Inf Dis 160:960–969

    Article  CAS  Google Scholar 

  • Almond N, Kent K, Cranage M, Rud E, Clarke B, Stott EJ (1995) Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345:1342–1344

    Article  PubMed  CAS  Google Scholar 

  • Baba TW, Jeong YS, Penninck D, Bronson R, Greene MF, Ruprech RM (1995) Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820–1825

    Article  PubMed  CAS  Google Scholar 

  • Bolognesi DP (1993) Human immunodeficiency virus vaccines. Adv Virus Res 42:103–148

    Article  PubMed  CAS  Google Scholar 

  • Bolognesi DP (1995) Ch. 20: The dilemma of developing and testing AIDS vaccines. In: Copper GM, Temin RG, and Sugden B (eds) The DNA provirus: Howard Temin’s scientific legacy. American Society for Microbiology, Washington, DC, pp 301–312

    Google Scholar 

  • Burns DPW, Desrosiers RC (1992) A caution on the use of SIV/HIV gag antigen detection system in neutralization assays. AIDS Res Hum Retroviruses 8:1189–1192

    Article  PubMed  CAS  Google Scholar 

  • Cox GJM, Zamb TJ, Babiuk LA (1993) Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol 67:5664–5667

    PubMed  CAS  Google Scholar 

  • Davis HL, Michel M-L, Whalen RG (1993) DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Human Mol Gen 2:1847–1851

    Article  CAS  Google Scholar 

  • Daniel MD, Kirchhoff F, Czajak SC, Simon MA, Sehgal PK, Desrosiers RC (1992) Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938–1941

    Article  PubMed  CAS  Google Scholar 

  • Daniel MD, Mazzara GP, Simon MA, Sehgal PK, Kodama T, Panicali DL, Desrosiers RC (1994) Hightiter immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. AIDS Res Hum Retroviruses 10:839–851

    PubMed  CAS  Google Scholar 

  • Dresser DW (1986) Immunization of experimental animals. In Weir DM (ed.): Immunochemistry, Handbook of Experimental Immunology, Blackwell Scientific Publications, Oxford, 1:8.1–8.21.

    Google Scholar 

  • Fuller DH, Haynes JR (1994) A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res Hum Retroviruses 10:1433–1441

    Article  PubMed  CAS  Google Scholar 

  • Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL (1993) DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations Proc Natl Acad Sci USA 90:11478–11482

    Article  PubMed  CAS  Google Scholar 

  • Giard M, Kieny M-P, Pinter A, Barre-Sinoussi F, Nara P, Kolbe H, Kusumi K, Chaput A, Reinhart T, Muchmore E, Ronco J, Kaczorek M, Gomard E, Gluckman J-C, Fultz PN (1991) Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci USA 88:542–546

    Article  Google Scholar 

  • Graham BS, Gorse GJ, Schwartz DH, Keefer MC, McElrath MJ, Matthews TJ, Wright PF, Belshe RB, Clements ML, Dolin R, Corey L, Bolognesi DP, Sin DM, Esterlitz JR, Hu S-L, Smith GE and NIAID AIDS vaccine clinical trials network. (1994) Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. J Infect Dis 170:782–786

    Article  PubMed  CAS  Google Scholar 

  • Haigwood NL, Nara PL, Brooks E, Van Nest GA, Ott G, Higgins KW, Dunlop N, Scandella CJ, Eichberg JW, Steimer KS (1992) Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. J Virol 66:172–182

    PubMed  CAS  Google Scholar 

  • Haynes BF (1993) Scientific and social issues of human immunodeficiency virus vaccine development. Science 260:1279–1286

    Article  PubMed  CAS  Google Scholar 

  • Heath SL, Tew JG, Tew JG Szakal AK, Burton GF (1995) Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377:740–744

    Article  PubMed  CAS  Google Scholar 

  • Herrmann JE, Chen SC, Fynan EF, Santoro JC, Greenberg HB, Robinson HL (1996) DNA vaccines against rotavirus infections. Arch Virol (in press)

    Google Scholar 

  • Hirsh VM, Johnson PR (1994) Pathogenic diversity of siman immunodeficiency viruses. Virus Research 32:183–203

    Article  Google Scholar 

  • Hu S-L, Stallard V, Abrams K, Barber GN, Kuller L, Langlois AJ, Morton WR, Benveniste RE (1993) Protection of vaccinia-primed macaques against SIVmac infection by combination immunization with recombinant vaccinia virus and SIVmne gp160. J Med Primatol 22:92–99

    PubMed  CAS  Google Scholar 

  • Javaherian K, Langlois AJ, Montefiori DC, Kent KA, Ryan KA, Wyman PD, Stott J, Bolognesi DP, Murphey-Corb M, LaRosa GJ (1994) Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. J Virol 68:2624–2631

    PubMed  CAS  Google Scholar 

  • Koup RA, Safrit JT, Cao Y, Andrews CA, Wu Y, McLeod G, Borkowsky W, Farthing C, Ho DD (1994) Temporal association of cellular immune response with the initial control of viremia in primary HIV-1 syndrome. J Virol 68:4650–4655

    PubMed  CAS  Google Scholar 

  • Li J, Haseltine W, Letvin NL, Sodroski J (1992) Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that express the HIV-1 envelope glycoprotein. J AIDS 5:639–664

    CAS  Google Scholar 

  • Letvin NL (1993) Vaccines against the human immunodeficiency viruses: progress and prospects. N Engl J Med 329:1400–1405

    Article  PubMed  CAS  Google Scholar 

  • Lu S, Santoro JC, Fuller DH, Haynes JR, Robinson HL (1995) Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 209:147–154

    Article  PubMed  CAS  Google Scholar 

  • Lu S, Arthos J, Montefiori DC, Yasutomi Y, Manson K, Mustafa F, Johnson E, Santoro JC, Wissink J, Mullins JI, Haynes JR, Letvin NL, Wyand M, Robinson HL (1996) Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol 70:3978–3991

    PubMed  CAS  Google Scholar 

  • Martins LP, Lau LI, Asano MS Ahmed R (1995) DNA vaccination against persistent viral infection. J Virol 69:2574–2582

    PubMed  CAS  Google Scholar 

  • Montefiori DC, Graham BS, Zhou JY, Zhou JT, Ahearn JM, and the National Institutes of Health AIDS Vaccine Clinical Trials Network (1994) Binding of human immunodeficiency virus 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. J Infect Dis 170:429–32

    Article  PubMed  CAS  Google Scholar 

  • Mor G, Klinman DM, Shapiro S, Hagiwara E, Sedegah M, Norman JA, Hoffman SL, Steinberg AD (1995) Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J Immunol 155:2039–2046

    PubMed  CAS  Google Scholar 

  • Putkonen P, Thorstensson R, Walther L, Albert J, Akerblom L, Granquist O, Wadell G, Norrby E, Biberfeld G (1991) Vaccine protection against HIV-2 infection in cynomolgus monkeys. AIDS Res Hum Retroviruses 7:271–277

    Article  PubMed  CAS  Google Scholar 

  • Putkonen P, Nilsson C, Walther L, Ghavamzadeh L, Hild K, Broliden K, Biberfeld G, Thorstensson R (1994) Efficacy of inactivated whole HIV-2 vaccines with various adjuvants in cynomolgus monkeys. J Med Primatol 23:89–94

    Article  PubMed  CAS  Google Scholar 

  • Robinson HL, Feltquate DM, Morin MJ, Haynes JR, Webster RG (1995) DNA vaccines: a new approach to immunization. In: Chanock RM, Brown F, Ginsberg HS and Norrby E (eds) Vaccines 95. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 69–75

    Google Scholar 

  • Sakuragi S, Shibata R, Mukai R, Komatsu T, Fukasawa M, Sakai H, Saduragi J-I, Kawamura M, Ibuki K, Hayami M, Adachi A (1992) Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus. J Gen Virol 73:2983–2987

    Article  PubMed  CAS  Google Scholar 

  • Shafferman A, Jahrling PB, Benveniste RE, Lewis MG, Phipps TJ, Eden-McCutchan F, Sadoff J, Eddy GA, Burke DS (1991) Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc Natl Acad Sci USA 88:7126–7130

    Article  PubMed  CAS  Google Scholar 

  • Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgonery DL, Liu MA (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745–1749

    Article  PubMed  CAS  Google Scholar 

  • Wang B, Ugen KE, Srikantan V, Agadmanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, Weiner DB (1993a) Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90:4156–4160

    Article  PubMed  CAS  Google Scholar 

  • Wang B, Boyer J, Srikantan V, Coney L, Carrano R, Phan C, Merva M, Dang K, Agadmanyan MG, Gilbert L, Ugen KE, Williams WV, Weiner DB (1993b) DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA and Cell Biology 12:799–805

    Article  PubMed  CAS  Google Scholar 

  • Wang B, Merva M, Dang K, Ugen KE, Williams WV, Weiner DB (1995a) Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Human Gene Therapy 6:407–418

    Article  PubMed  CAS  Google Scholar 

  • Wang B, Boyer JD, Ugen KE, Srikantan V, Ayyaroo V, Agadmanyan MG, Williams WV, Newman M, Coney L, Carrano R, Weiner DB (1995b) Nucleic acid-based immunization against HIV-1: induction of protective in vivo immune responses. AIDS 9(suppl A):S159–S170

    PubMed  Google Scholar 

  • Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, Desrosiers RC (1996) Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 70:3724–3733

    PubMed  CAS  Google Scholar 

  • Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HCJ (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132–140

    Article  PubMed  CAS  Google Scholar 

  • Yasutomi Y, Reimann KA, Lord CI, Miller MD, Letvin NL (1993) Simian immunodeficiency virus- specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J Virol 67:1707–1711

    PubMed  CAS  Google Scholar 

  • Yasutomi Y, Robinson HL, Lu S, Mustafa F, Lekutis C, Arthos J, Mullins J, Voss G, Manson K, Wyand M, Letvin NL (1996) Simian immunodeficiency virus-specific cytotoxic T lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol 70:678–681

    PubMed  CAS  Google Scholar 

  • Zarozinski CC, Fynan EF, Selin LK, Robinson HL, Welsh RM (1995) Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J Immunol 154:4010–4017

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lu, S. (1998). Developing DNA Vaccines Against Immunodeficiency Viruses. In: Koprowski, H., Weiner, D.B. (eds) DNA Vaccination/Genetic Vaccination. Current Topics in Microbiology and Immunology, vol 226. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80475-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-80475-5_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-80477-9

  • Online ISBN: 978-3-642-80475-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics